Portland Investment Counsel Inc. Isoray, Inc. Transaction History

Portland Investment Counsel Inc.

$318 Million
Q4 2024

A detailed history of Portland Investment Counsel Inc. transactions in Isoray, Inc. stock. As of the latest transaction made, Portland Investment Counsel Inc. holds 150,000 shares of ISR stock, worth $103,499. This represents 0.03% of its overall portfolio holdings.

Number of Shares

150,000

Previous 70,001 114.28%

Holding current value

$103,499

Previous $48,000 114.58%

% of portfolio

0.03%

Previous 0.02%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	N/A	79,999 Added 114.28%	150,000 $103,000
Q2 2024 Aug 14, 2024	SELL	N/A	-272,549 Reduced 79.56%	70,001 $48,000
Q1 2024 May 14, 2024	BUY	N/A	200,000 Added 140.3%	342,550 $408,000
Q4 2023 Feb 14, 2024	BUY	N/A	142,550 New	142,550 $57,000
Q2 2023 Aug 14, 2023	BUY	$0.0 - $0.69 $0 - $713,529	1,034,100 New	1,034,100 $683,000

Others Institutions Holding ISR

# of Institutions

Shares Held

225K

Call Options Held

Put Options Held

Bergan Kdv Wealth Management, LLC

75K
Shares

$51,749
0.01% of portfolio

View Full List

About Isoray, Inc.

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

More about ISR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.

Account

Portland Investment Counsel Inc. Isoray, Inc. Transaction History